All Stories

  1. Exercise blood pressure response does not differentiate endurance athletes with paroxysmal atrial fibrillation
  2. National Funding for Cardiac Arrest Research in Australia: An Analysis of Competitive Grant Schemes
  3. Electroanatomical Mapping May Identify Concealed Arrhythmogenic Cardiomyopathy in Endurance Athletes With Complex Ventricular Arrhythmias
  4. Scleroderma clinical trials consortium classification criteria for systemic sclerosis heart involvement
  5. Exercise blood pressure relative to fitness and cardiovascular outcomes: the EXERTION study
  6. Moving From Eyeball Assessment to Quantification of the Right Ventricular “Hot Spot” in Arrhythmogenic Cardiomyopathy
  7. Arrhythmias and structural remodeling in lifelong and retired master endurance athletes
  8. Reduced PI3K(p110α) induces atrial myopathy, and PI3K-related lipids are dysregulated in athletes with atrial fibrillation
  9. “Letter to “Pathological contributors to organ damage and mortality in systemic sclerosis: A nationwide matched case-control study”: Author's Reply
  10. Maybe Valsalva, but please consider big hearts in middle-aged athletes as an explanation for atrial fibrillation prevalence
  11. Left atrioventricular ratio (LA:LV): using left ventricular size as the reference for identifying maladaptive left atrial remodelling
  12. Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  13. Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes
  14. Balancing Exercise Benefits Against Heartbeat Consumption in Elite Cyclists
  15. Mechanistic Insights Into Reduced Arrhythmia Prevalence in Female Endurance Athletes
  16. Similar But Different
  17. Pathological contributors to organ damage and mortality in systemic sclerosis: a nationwide matched case-control study
  18. Trends and differences in the rates of autopsy in the United States, 2003 to 2020: A nationwide analysis
  19. The term ‘athlete’s heart’ encapsulates both male and female athletic hearts if indexed correctly
  20. Exercise in Inherited Cardiomyopathies: Optimizing the Dose-Response Curve
  21. Atrial fibrillation in former world-class rowers: role of environmental and genetic factors
  22. Validation of magnetic resonance imaging-derived venous oxygen saturation and oxygen consumption measurements during exercise
  23. Cardiac arrest in the Australian Alps: A 20-year analysis
  24. Female endurance athletes: smaller hearts but similar relationship between ventricular size, fitness and fibrosis as male athletes
  25. Recommendations for cardiac screening and emergency action planning in youth football: a FIFA consensus statement
  26. Correction to: Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  27. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities: A Scientific Statement From the American Heart Association and American College of Cardiology
  28. Cardiac arrest in Australia: a call to action
  29. Insights From a 20-Year Follow-Up of the First Heart Transplant Recipient to Complete an Ironman Triathlon
  30. Stepping up physical activity and fitness is needed for longevity
  31. Clinical Considerations for Competitive Sports Participation for Athletes With Cardiovascular Abnormalities
  32. Location of Left Ventricular Outflow Tract Measurements for Stroke Volume Estimation With Echocardiography
  33. Genetics, Fitness, and Left Ventricular Remodelling: The Current State of Play
  34. Your Heart Can’t See What Sneakers You Are Wearing: Exercise Training Load in Endurance Athletes Is Inadequately Quantified in Sports Cardiology
  35. Editorial commentary: Exercise recommendations in hypertrophic cardiomyopathy shouldn't end at the recommendation
  36. Proposed minimum dataset for an athlete screening echocardiogram: the Standardised Transthoracic Echocardiogram Reporting in Athletes (STERA) protocol
  37. Preventing Allogeneic Stem Cell Transplant–Related Cardiovascular Dysfunction: ALLO-Active Trial
  38. RETRACTED AND REPLACED: Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease
  39. The role of multi-modality imaging for the assessment of left atrium and left atrial appendage: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA) of the European Socie...
  40. Coronary atherosclerosis in athletes: emerging concepts and preventive strategies
  41. Cardiac arrhythmia assessment with patch electrocardiogram versus insertable cardiac monitor: a cohort study in endurance athletes with atrial fibrillation
  42. Small Heart Size and Premature Death in 366,484 Individuals With Normal Ejection Fraction
  43. Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank
  44. Comparison of 6-lead smartphone ECG and 12-lead ECG in athletes and a genetic heart disease population
  45. Ventricular arrhythmias in association with athletic cardiac remodelling
  46. A Call to Action to Improve Cardiac Arrest Outcomes: A Report From the National Summit for Cardiac Arrest
  47. Research Priorities for Atrial Fibrillation in Australia: A Statement From the Australian Cardiovascular Alliance Clinical Arrhythmia Theme
  48. Insights on blood pressure response to graded exercise in males and females across the age and fitness spectrum: reply
  49. Cardiorespiratory Fitness in Childhood Cancer Survivors: A Systematic Review and Meta-Analysis
  50. 2024 HRS expert consensus statement on arrhythmias in the athlete: Evaluation, treatment, and return to play
  51. Diversity of ICD-10 coding for sudden arrhythmic death syndrome is likely to create a spurious rise in cases under new ICD-11 nomenclature
  52. Lifelong physiology of a former marathon world-record holder: the pros and cons of extreme cardiac remodeling
  53. Physiological Insights From Asymptomatic Severe Valvular Disease in a Highly Trained Athlete
  54. Rationale and Design of the Australasian Registry of Screening ECGs in National Athletes Project
  55. Blood pressure response to graded bicycle exercise in males and females across the age and fitness spectrum
  56. Cancer Therapy and Exercise Intolerance: The Heart Is But a Part
  57. Histological evaluation of cardiac remodelling in equine athletes
  58. The Oxygen Cascade According to HFpEF Likelihood
  59. International Criteria for Reporting Study Quality for Sudden Cardiac Arrest/Death Tool
  60. 2024 CSANZ Position Statement on Indications, Assessment and Monitoring of Structural and Valvular Heart Disease With Transthoracic Echocardiography in Adults
  61. Physiological determinants of decreased peak leg oxygen uptake in chronic disease: a systematic review and meta-analysis
  62. Prevalence of atrial septal defects and patent foramen ovale in a cohort of sudden cardiac death patients undergoing autopsy
  63. Prognostic and functional importance of both overt and subclinical left ventricular systolic dysfunction in systemic sclerosis
  64. Response to: Regard to assessing agreement between two raters with kappa statistics
  65. The aortic paradox: a nationwide analysis of 523 994 individual echocardiograms exploring fatal aortic dissection
  66. Outrunning the grim reaper: longevity of the first 200 sub-4 min mile male runners
  67. Characterizing the influence of cardiorespiratory fitness on left atrial size and function in the general population
  68. Integrating Cardio-Oncology Across the Research Pipeline, Policy, and Practice in Australia—An Australian Cardiovascular Alliance Perspective
  69. Reduced Ejection Fraction in Elite Endurance Athletes: Clinical and Genetic Overlap With Dilated Cardiomyopathy
  70. Sex disparities in bystander defibrillation for out-of-hospital cardiac arrest
  71. Toxicology Screening in Sports-Related Sudden Cardiac Death
  72. Determinants of Impaired Peak Oxygen Uptake in Breast Cancer Survivors: JACC: CardioOncology Primer
  73. Contribution of Left Ventricular Diastolic Dysfunction to Survival and Breathlessness in Systemic Sclerosis–Associated Interstitial Lung Disease
  74. The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre
  75. Lessons learnt in the first year of an Australian pediatric cardio oncology clinic
  76. Clinical outcomes of 10 years of cardiac screening in elite New Zealand athletes
  77. Prevalence of Multiple Causes of Death Within Young and Middle-Aged People Experiencing Sudden Cardiac Arrest
  78. Resuscitation of people with a do-not-resuscitate order: When does it happen and what are the outcomes?
  79. A Review on the Role of Exercise Training to Prevent a Decline in Cardiorespiratory Fitness and Cardiac Function in Breast Cancer Survivors
  80. Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation
  81. Effect of Exercise Training on Peak Aerobic Power After Heart Transplantation: A Brief Review
  82. Epidemiology of pediatric out-of-hospital cardiac arrest compared with adults
  83. Understanding Exercise Capacity: From Elite Athlete to HFpEF
  84. Ms-represented: strategies to increase female representation in sports cardiology research
  85. Extracorporeal cardiopulmonary resuscitation for refractory cardiac arrest in Australia: a narrative review
  86. A two-point strategy to clarify prognosis in >80 year olds experiencing out of hospital cardiac arrest
  87. Influence of exercise training on the left atrium: implications for atrial fibrillation, heart failure, and stroke
  88. Prevalence of illicit drug use in young patients with sudden cardiac death
  89. Sudden cardiac death, arrhythmias and abnormal electrocardiography in systemic sclerosis: A systematic review and meta-analysis
  90. Multidisciplinary team discussion: the emerging gold standard for management of cardiopulmonary complications of connective tissue disease
  91. Associations between postrace atrial fibrillation and measures of performance, racing history and airway disease in horses
  92. Measurement of Stroke Volume With Echocardiography Compared to Gold Standard Cardiac Magnetic Resonance Imaging: An Observational Study
  93. Reply
  94. Semiautomatic Training Load Determination in Endurance Athletes
  95. The New South Wales Sudden Cardiac Arrest Registry: A Data Linkage Cohort Study
  96. Vascular Aging Is Accelerated in Hematological Cancer Survivors Who Undergo Allogeneic Stem Cell Transplant
  97. Sudden Cardiac Death in People With Schizophrenia
  98. Exercise-induced myocardial T1 increase and right ventricular dysfunction in recreational cyclists: a CMR study
  99. New-onset atrial fibrillation prediction: the HARMS2-AF risk score
  100. Return to play after myocarditis: time to abandon the one-size-fits-all approach?
  101. Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction
  102. Too Little of a Good Thing
  103. Athlete's Heart: A Cardiovascular Step-By-Step Multimodality Approach
  104. No Association Between Out-of-Hospital Cardiac Arrest and COVID-19 Vaccination
  105. A systematic review of global autopsy rates in all-cause mortality and young sudden death
  106. Declining Recognition of Chest Pain as a Cardiac Symptom Should Act as a Shot in The Arm
  107. Effects of training adaption in endurance athletes with atrial fibrillation: protocol for a multicentre randomised controlled trial
  108. Lifelong endurance exercise and its relation with coronary atherosclerosis
  109. Cardioprotection Using Strain-Guided Management of Potentially Cardiotoxic Cancer Therapy
  110. Exercise-Induced Cardiac Remodeling and Atrial Fibrillation in Female Endurance Athletes
  111. Exercise for the Prevention of Anthracycline-Induced Functional Disability and Cardiac Dysfunction: The BREXIT Study
  112. Reduced cardiovascular reserve capacity in long-term allogeneic stem cell transplant survivors
  113. Disease specific determinants of cardiopulmonary fitness in systemic sclerosis
  114. In a large primary care dataset, the CHA₂DS₂-VASc score leads to almost universal recommendation for anticoagulation treatment in those aged ≥65 years with atrial fibrillation
  115. Aerosol Generation During High Intensity Exercise—Implications for COVID-19 Transmission
  116. Rapid cardiovascular aging following allogeneic hematopoietic cell transplantation for hematological malignancy
  117. Cardio-Oncology Recommendations for Pediatric Oncology Patients
  118. Late Afternoon Vigorous Exercise Increases Postmeal but Not Overnight Hypoglycemia in Adults with Type 1 Diabetes Managed with Automated Insulin Delivery
  119. Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre‐capillary pulmonary hypertension
  120. Relating QRS voltages to left ventricular mass and body composition in elite endurance athletes
  121. The flatlining of cardiac arrest survival: can we revive the upward trend?
  122. The clinical implications of left ventricular diastolic dysfunction in systemic sclerosis
  123. Clinical and Pathologic Features of Out-of-Hospital Cardiac Arrest in Pregnancy
  124. Factors predicting cardiac arrest in acute coronary syndrome patients under 50: A state-wide angiographic and forensic evaluation of outcomes
  125. The Athlete’s Heart—Challenges and Controversies
  126. Type-2 Diabetes and the Clinical Importance of Exaggerated Exercise Blood Pressure
  127. Three-dimensional echocardiography of the athlete’s heart: a comparison with cardiac magnetic resonance imaging
  128. Inconsistent discharge diagnoses for young cardiac arrest episodes: insights from a statewide registry
  129. Analysis of athlete QT intervals by age: Fridericia and Hodges heart rate corrections outperform Bazett for athlete ECG screening
  130. Determinants of oxygen utilization in breast cancer: Similarities between heart failure with preserved ejection fraction
  131. Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome
  132. Obesity in young sudden cardiac death: Rates, clinical features, and insights into people with body mass index >50kg/m2
  133. Reduced death rates of elite Australian Rules footballers compared to age-matched general population
  134. Why Me? The Rise of Patients Without Traditional Cardiovascular Risk Factors
  135. Causes, circumstances, and potential preventability of cardiac arrest in the young: insights from a state-wide clinical and forensic registry
  136. Sudden cardiac death related to physical exercise in the young: a nationwide cohort study of Australia
  137. Preventing the adverse cardiovascular consequences of allogeneic stem cell transplantation with a multi-faceted exercise intervention: the ALLO-Active trial protocol
  138. Soldiers’ Heart: A Prospective Study of Cardiac Remodeling in Soldiers Undergoing Progressive Intensity Exercise Training
  139. Anabolic steroid misuse is an important reversible cause of cardiomyopathy: a case report
  140. Prevalence of Coronary Artery Anomalies in Young and Middle-Aged Sudden Cardiac Death Victims (from a Prospective State-Wide Registry)
  141. Return to exercise post-COVID-19 infection: A pragmatic approach in mid-2022
  142. Diastolic flow in the left ventricular outflow tract – A normal physiological and underappreciated echocardiographic finding
  143. Higher rates but similar causes of young out‐of‐hospital cardiac arrest in rural Australian patients
  144. The Impact of Ethnicity on Athlete ECG Interpretation: A Systematic Review
  145. On the characterization of athlete’s heart using 3D echocardiography
  146. Predictors and outcomes of in-hospital referrals for forensic investigation after young sudden cardiac death
  147. Risk Factors for Exercise-Associated Sudden Cardiac Death in Thoroughbred Racehorses
  148. Tackling an unmet need in sports cardiology: understanding exercise-induced cardiac remodelling and its clinical consequences
  149. Using magnetic resonance imaging to map the hidden burden of muscle involvement in systemic sclerosis
  150. Arrhythmogenic Right Ventricular Cardiomyopathy
  151. Diverse stakeholder engagement at the heart of co-designing cardiac arrest care
  152. Fit, Female or Fifty–Is Cardiac Rehabilitation “Fit” for Purpose for All? A Systematic Review and Meta-Analysis With Meta-Regression
  153. Use of a smartphone electrocardiogram to diagnose arrhythmias during exercise in athletes: a case series
  154. Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography
  155. The dysfunctional right ventricle: the importance of multi-modality imaging
  156. Postmortem Interrogation of Cardiac Implantable Electronic Devices
  157. Rationale and design of the PROspective ATHletic Heart (Pro@Heart) study: long-term assessment of the determinants of cardiac remodelling and its clinical consequences in endurance athletes
  158. A Comprehensive Approach to Managing Methamphetamine-Associated Cardiomyopathy
  159. Myocardial fibrosis and arrhythmic burden in systemic sclerosis
  160. Intracoronary IgG4-related disease as an unusual cause of sudden cardiac arrest: a case series
  161. Arrhythmogenic Right Ventricular Cardiomyopathy With Right Ventricular Thrombus Found Incidentally on a Trauma CT Scan
  162. Disease Specific Determinants of Cardiopulmonary Fitness in Systemic Sclerosis
  163. Response by Howden et al to Letter Regarding Article, “Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension”
  164. Role of plakophilin-2 expression on exercise-related progression of arrhythmogenic right ventricular cardiomyopathy: a translational study
  165. A Randomized Crossover Trial Comparing Glucose Control During Moderate-Intensity, High-Intensity, and Resistance Exercise With Hybrid Closed-Loop Insulin Delivery While Profiling Potential Additional Signals in Adults With Type 1 Diabetes
  166. Athletes with mild COVID-19 illness demonstrate subtle imaging abnormalities without exercise impairment or arrhythmias
  167. Cardiorespiratory Fitness, Workload, and the Blood Pressure Response to Exercise Testing
  168. Multiday cycles of heart rate are associated with seizure likelihood: An observational cohort study
  169. Sudden Cardiac Death in Systemic Sclerosis: Diagnostics to Assess Risk and Inform Management
  170. Right ventricular and cyclic guanosine monophosphate signalling abnormalities in stages B and C of heart failure with preserved ejection fraction
  171. First Randomized Controlled Trial of Hybrid Closed Loop Versus Multiple Daily Injections or Insulin Pump Using Self-Monitoring of Blood Glucose in Free-Living Adults with Type 1 Diabetes Undertaking Exercise
  172. Prevention of Pathological Atrial Remodeling and Atrial Fibrillation
  173. The economic impact of sudden cardiac arrest
  174. Exercise oscillatory ventilation during autonomic blockade in young athletes and healthy controls
  175. Oxygen Pathway Limitations in Patients With Chronic Thromboembolic Pulmonary Hypertension
  176. Comparison between a 6‑lead smartphone ECG and 12‑lead ECG in athletes
  177. The End Unexplained Cardiac Death (EndUCD) Registry for Young Australian Sudden Cardiac Arrest
  178. Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET)
  179. Athletes with valvular heart disease and competitive sports: a position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology
  180. Endurance exercise and the risk of cardiovascular pathology in men: a comparison between lifelong and late-onset endurance training and a non-athletic lifestyle - rationale and design of the Master@Heart study, a prospective cohort trial
  181. Response to Sanchis-Gomar et al. ‘Atrial fibrillation in athletes and non-athletes: evidence of different causative mechanisms’
  182. Optimal Detection of Cardiac Sequelae
  183. The effect of posture on maximal oxygen uptake in active healthy individuals
  184. Prescribing Exercise in Early-Stage Breast Cancer During Chemotherapy: A Simple Periodized Approach to Align With the Cyclic Phases of Chemotherapy
  185. Traditional markers of cardiac toxicity fail to detect marked reductions in cardiorespiratory fitness among cancer patients undergoing anti-cancer treatment
  186. The Australia and New Zealand Cardio‐Oncology Registry: evaluation of chemotherapy‐related cardiotoxicity in a national cohort of paediatric cancer patients
  187. Exercise-Induced Arrhythmogenic (Right Ventricular) Cardiomyopathy Is Real…if you Consider it
  188. Predicting Left Ventricular Mass Using ECG, Demographic and DXA Features
  189. Acute glycaemic management before, during and after exercise for cardiac rehabilitation participants with diabetes mellitus: a joint statement of the British and Canadian Associations of Cardiovascular Prevention and Rehabilitation, the International C...
  190. Proof that exercise works, now it’s time for optimizing delivery to our patients with pulmonary hypertension
  191. Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise?
  192. Mind the gap: Knowledge deficits in evaluating young sudden cardiac death
  193. Persistent Troponin Elevation in Left-Dominant Arrhythmogenic Cardiomyopathy
  194. Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVID-19
  195. Multiday cycles of heart rate are associated with seizure likelihood
  196. Can post-mortem coronary artery calcium scores aid diagnosis in young sudden death?
  197. Smoke but no fire: increased myocardial infarction with normal coronary arteries in the Australian bushfires?
  198. Reassuring News for Athletes With Atrial Fibrillation, But Perhaps Not All Athletes
  199. Measuring atrial stasis during sinus rhythm in patients with paroxysmal atrial fibrillation using 4 Dimensional flow imaging
  200. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
  201. The effect of exercise training on cardiometabolic health in men with prostate cancer receiving androgen deprivation therapy: a systematic review and meta-analysis
  202. Differing mechanisms of atrial fibrillation in athletes and non-athletes: alterations in atrial structure and function
  203. Helping patients to help themselves: informing individuals predisposed to arrhythmogenic cardiomyopathy
  204. Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
  205. Prospective long-term follow-up analysis of the cardiovascular system in marathon runners: study design of the Pro-MagIC study
  206. Audit of a cardiac screening policy for elite Australian cricketers
  207. Left Ventricular Fibrosis in Middle-Age Athletes and Physically Active Adults
  208. Left ventricular remodeling in elite and sub‐elite road cyclists
  209. Exercise and Arrhythmogenic Right Ventricular Cardiomyopathy
  210. Reduced Exercise Capacity in Diabetes Mellitus Is Not Associated with Impaired Deformation or Twist
  211. The Utility of Cardiac Reserve for the Early Detection of Cancer Treatment-Related Cardiac Dysfunction: A Comprehensive Overview
  212. Cardiac screening of athletes: consensus needed for clinicians on indications for follow-up echocardiography testing
  213. Cardiovascular Screening of Elite Athletes by Sporting Organizations in Australia: A Survey of Chief Medical Officers
  214. Fears of a Big Bang for Rugby Players, Urgent Validation Required
  215. Association between physical activity and risk of incident arrhythmias in 402 406 individuals: evidence from the UK Biobank cohort
  216. Multiday Cycles of Heart Rate Modulate Seizure Likelihood at Daily, Weekly and Monthly Timescales: An Observational Cohort Study
  217. Exercise cardiovascular magnetic resonance: development, current utility and future applications
  218. Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness
  219. Cardiac arrest and sudden cardiac death registries: a systematic review of global coverage
  220. The Cardiac Society of Australia and New Zealand Position Statement on the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy (2019 Update)
  221. Glucose and Counterregulatory Responses to Exercise in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia Using Closed-Loop Insulin Delivery: A Randomized Crossover Study
  222. Echocardiographic Assessment of Left Ventricular Remodeling in American Style Footballers
  223. Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
  224. Right Ventricular Function
  225. Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta‐Analysis
  226. Pulmonary vascular remodelling in athletes: an anti-concept to be proved
  227. Atrial fibrillation in athletes: different but the same?
  228. Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias
  229. ECG-based cardiac screening programs: Legal, ethical, and logistical considerations
  230. Brief recommendations for participation in leisure time or competitive sports in athletes–patients with coronary artery disease: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  231. Impaired Cardiac Reserve and Abnormal Vascular Load Limit Exercise Capacity in Chronic Thromboembolic Disease
  232. Sildenafil enhances central hemodynamic responses to exercise, but not V̇o2peak, in people with diabetes mellitus
  233. Brief recommendations for participation in competitive sports of athletes with arterial hypertension: Summary of a Position Statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  234. Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association
  235. Heart Rate Reserve in Fontan Patients: Chronotropic Incompetence or Hemodynamic Limitation?
  236. Unsupervised respiratory signal extraction from ungated cardiac magnetic resonance imaging at rest and during exercise
  237. Persistent Impairment in Cardiopulmonary Fitness after Breast Cancer Chemotherapy
  238. Relation of Alcohol Consumption to Left Ventricular Fibrosis Using Cardiac Magnetic Resonance Imaging
  239. Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis
  240. Pulmonary Hypertension
  241. Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
  242. Sudden Death and Ventricular Arrhythmias in Athletes: Screening, De-Training and the Role of Catheter Ablation
  243. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the Sport Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  244. Electrocardiographic Features Differentiating Arrhythmogenic Right Ventricular Cardiomyopathy From an Athlete’s Heart
  245. Measurement of microvascular function in patients presenting with thrombolysis for ST elevation myocardial infarction, and PCI for non-ST elevation myocardial infarction
  246. Regular Alcohol Consumption Is Associated With Impaired Atrial Mechanical Function in the Atrial Fibrillation Population
  247. Exercise as a diagnostic and therapeutic tool for the prevention of cardiovascular dysfunction in breast cancer patients
  248. Misclassification of cricket in the American College of Cardiology (ACC) Task Force classification of sports
  249. Advanced Imaging to Phenotype Patients With a Systemic Right Ventricle
  250. Acute metabolic and cardiovascular effects of mirabegron in healthy individuals
  251. Drugs in Sport — A Change is Needed, but What?
  252. Sports Cardiology – A Bona Fide Sub-Specialty
  253. Sports Cardiology – Example Illustrative Cases
  254. Athlete’s Heart: Is the Morganroth Hypothesis Obsolete?
  255. Standing up to the cardiometabolic consequences of hematological cancers
  256. What May the Future Hold for Sports Cardiology?
  257. Recommendations for participation in competitive sports of athletes with arterial hypertension: a position statement from the sports cardiology section of the European Association of Preventive Cardiology (EAPC)
  258. Rationale and Design of the Strain Surveillance of Chemotherapy for Improving Cardiovascular Outcomes
  259. Single Versus Standard Multiview Assessment of Global Longitudinal Strain for the Diagnosis of Cardiotoxicity During Cancer Therapy
  260. Recommendations for participation in leisure time or competitive sports in athletes-patients with coronary artery disease: a position statement from the Sports Cardiology Section of the European Association of Preventive Cardiology (EAPC)
  261. Right Heart-Pulmonary Circulation Unit in Cardiomyopathies and Storage Diseases
  262. The Right Heart International Network (RIGHT-NET)
  263. The ventricular residence time distribution derived from 4D flow particle tracing: a novel marker of myocardial dysfunction
  264. Atrial remodeling and ectopic burden in recreational athletes: Implications for risk of atrial fibrillation
  265. Exercise cardiac magnetic resonance to differentiate athlete’s heart from structural heart disease
  266. Exercise Blood Pressure Guidelines: Time to Re-evaluate What is Normal and Exaggerated?
  267. Exercise capacity in diabetes mellitus is predicted by activity status and cardiac size rather than cardiac function: a case control study
  268. Diagnosis and Significance of Pulmonary Microvascular Disease in Diabetes
  269. Mechanisms of the Improvement in Peak VO 2 With Exercise Training in Heart Failure With Reduced or Preserved Ejection Fraction
  270. The Right Ventricle: From Bench to Bedside
  271. Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  272. New International Guidelines for the Interpretation of the Electrocardiograph in Athletes: a “Traffic Light” Tool for Maximising Diagnostic Specificity
  273. Atrial deformation in athletes with AF: chronic adverse remodelling or transient mechanical stunning?
  274. Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans
  275. Blood Pressure Response to Exercise and Cardiovascular Disease
  276. Chemotherapy-related cardiotoxicity: are Australian practitioners missing the point?
  277. A focus on the greatness of the lesser circulation - Spotlight Issue on the Right Ventricle
  278. State of the Art Review: Atrial Fibrillation in Athletes
  279. Point:Counterpoint
  280. Exercise and the right ventricle: a potential Achilles’ Heel
  281. Safety Concerns regarding article: Reliability and Validity of a Self-paced Cardiopulmonary Exercise Test in Post-MI Patients. L. A. Jenkins, A. Mauger, J. Fisher, J. Hopker. Int J Sports Med 2017; 38: 300–306.
  282. SASHA versus ShMOLLI: a comparison of T1 mapping methods in health and dilated cardiomyopathy at 3 T
  283. Closed-Loop Insulin Delivery for Adults with Type 1 Diabetes Undertaking High-Intensity Interval Exercise Versus Moderate-Intensity Exercise: A Randomized, Crossover Study
  284. Pulmonary Vascular Function During Exercise
  285. International criteria for electrocardiographic interpretation in athletes: Consensus statement
  286. International recommendations for electrocardiographic interpretation in athletes
  287. International Recommendations for Electrocardiographic Interpretation in Athletes
  288. Right ventricular and pulmonary vascular reserve in asymptomatic BMPR2 mutation carriers
  289. Cardiovascular Effects of Performance-Enhancing Drugs
  290. Right ventricular dilatation and function
  291. Increased Flow, Dam Walls, and Upstream Pressure
  292. Atrial volume and function during exercise in health and disease
  293. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  294. Pre-participation cardiovascular evaluation for athletic participants to prevent sudden death: Position paper from the EHRA and the EACPR, branches of the ESC. Endorsed by APHRS, HRS, and SOLAECE
  295. Pathophysiology of exercise intolerance in breast cancer survivors with preserved left ventricular ejection fraction
  296. Sports Cardiology
  297. A Modern Definition of the Athlete’s Heart—for Research and the Clinic
  298. Sports Cardiology: Comprehensive Clinical Care for Athletes and Highly Active Individuals
  299. Idiopathic Ventricular Tachycardia/Ventricular Fibrillation
  300. Letter by Heidbuchel et al Regarding Article, “Right and Left Ventricular Function and Mass in Male Elite Master Athletes: A Controlled Contrast-Enhanced Cardiovascular Magnetic Resonance Study”
  301. Stressing the right ventricular-pulmonary vascular unit: beyond pulmonary vascular resistance
  302. Effect of Experience and Training on the Concordance and Precision of Strain Measurements
  303. Acute effect of static exercise in patients with aortic regurgitation assessed by cardiovascular magnetic resonance: role of left ventricular remodelling
  304. Exercise-induced cardiac fatigue: the need for speed
  305. Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study
  306. Accuracy of Echocardiography to Evaluate Pulmonary Vascular and RV Function During Exercise
  307. The Potential Cardiotoxic Effects of Exercise
  308. review of the current status of experimental models for Systems Biology research
  309. Exercise-induced pulmonary oedema in endurance triathletes
  310. Let's keep running… exercise, basic science and the knowledge gaps
  311. Effect of respiration on cardiac filling at rest and during exercise in Fontan patients: A clinical and computational modeling study
  312. Understanding the Mechanism of T-Wave Inversion in Athletes May Be Key to Best Management
  313. T-wave subtleties in screened athletes: sharpening the lead or whittling the pencil away?
  314. Reply to Sanchis-Gomar et al.—Undeniable Benefits of Exercise Should Not Preclude Inquiry Into the Mechanisms of Arrhythmias in Athletes
  315. Young Women With Abdominal Obesity Have Subclinical Myocardial Dysfunction
  316. Subepicardial delayed gadolinium enhancement in asymptomatic athletes: let sleeping dogs lie?
  317. Early repolarization patterns associated with increased arrhythmic risk are common in young non-Caucasian Australian males and not influenced by athletic status
  318. Relationship between Inflammatory Cytokines and Indices of Cardiac Dysfunction following Intense Endurance Exercise
  319. Response to Letters Regarding Article, “Can Intensive Exercise Harm the Heart? You Can Get Too Much of a Good Thing”
  320. Exercise-induced right ventricular dysfunction is associated with ventricular arrhythmias in endurance athletes
  321. Abnormal right ventricular relaxation in pulmonary hypertension
  322. Correction
  323. Right ventricular suction: an important determinant of cardiac performance
  324. Signs of RV overload on the athlete’s ECG
  325. Let's keep running… exercise, basic science and the knowledge gaps
  326. Physiologic and pathophysiologic changes in the right heart in highly trained athletes
  327. Is Exercise Good for the Right Ventricle? Concepts for Health and Disease
  328. Pulmonary Vascular and Right Ventricular Reserve in Patients With Normalized Resting Hemodynamics After Pulmonary Endarterectomy
  329. Right Precordial T-Wave Inversion in Healthy Endurance Athletes Can Be Explained by Lateral Displacement of the Cardiac Apex
  330. Exercise pathophysiology and sildenafil effects in chronic thromboembolic pulmonary hypertension
  331. Straining the RV to Predict the Future∗
  332. Acute effect of static exercise on the cardiovascular system: assessment by cardiovascular magnetic resonance
  333. Modest agreement in ECG interpretation limits the application of ECG screening in young athletes
  334. Defining the interaction between exercise and arrhythmogenic right ventricular cardiomyopathy
  335. Author response
  336. Exercise and Cardiovascular Risk in Patients With Hypertension
  337. The right ventricle following prolonged endurance exercise: are we overlooking the more important side of the heart? A meta-analysis
  338. Exercise blood pressure: clinical relevance and correct measurement
  339. Fluoroscopic Ring of Pannus within a Mechanic Mitral Valve: A Novel Sign of Calcified Pannus Infiltration
  340. Right Heart Structural and Functional Remodeling in Athletes
  341. Can Intensive Exercise Harm the Heart?: You Can Get Too Much of a Good Thing
  342. Can Intensive Exercise Harm the Heart?: The Benefits of Competitive Endurance Training for Cardiovascular Structure and Function
  343. The response of the pulmonary circulation and right ventricle to exercise: exercise-induced right ventricular dysfunction and structural remodeling in endurance athletes (2013 Grover Conference series)
  344. Right Ventricular Fatigue Developing during Endurance Exercise
  345. Comparison of Frequency of Significant Electrocardiographic Abnormalities in Endurance Versus Nonendurance Athletes
  346. Sildenafil Improves Exercise Hemodynamics in Fontan Patients
  347. Interaction between respiration and right versus left ventricular volumes at rest and during exercise: a real-time cardiac magnetic resonance study
  348. Right Ventricular Structure and Function During Exercise
  349. The Impact of Long-Term Endurance Sports on the Right Ventricle: Evidence for Exercise-Induced Arrhythmogenic RV Cardiomyopathy
  350. Transit of micro-bubbles through the pulmonary circulation of Thoroughbred horses during exercise
  351. Cardiac Imaging and Stress Testing Asymptomatic Athletes to Identify Those at Risk of Sudden Cardiac Death
  352. Atrial fibrillation in athletes and the interplay between exercise and health
  353. To assess exertional breathlessness you must exert the breathless
  354. Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
  355. The Seattle Criteria increase the specificity of preparticipation ECG screening among elite athletes
  356. Response to Letter Regarding Article, "Cardiac Magnetic Resonance Imaging: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise"
  357. Reduced Right Ventricular Myocardial Strain in the Elite Athlete May Not Be a Consequence of Myocardial Damage.“Cream Masquerades as Skimmed Milk”
  358. Exercise-Induced Arrhythmogenic Right Ventricular Cardiomyopathy
  359. Can Intense Endurance Exercise Cause Myocardial Damage and Fibrosis?
  360. Cardiac MRI: A New Gold Standard for Ventricular Volume Quantification During High-Intensity Exercise
  361. Ventricular arrhythmias associated with long-term endurance sports: what is the evidence?
  362. Targeted therapies in breast cancer: are heart and vessels also being targeted?
  363. The right heart in athletes
  364. The right heart in athletes
  365. The athlete's heart
  366. Exercise Strain Rate Imaging Demonstrates Normal Right Ventricular Contractile Reserve and Clarifies Ambiguous Resting Measures in Endurance Athletes
  367. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
  368. Asymmetric collimation can significantly reduce patient radiation dose during pulmonary vein isolation†
  369. Should Pre-participation Cardiovascular Screening for Competitive Athletes be Introduced in Australia? A Timely Debate in a Sport-loving Nation
  370. Maximal oxygen consumption is best predicted by measures of cardiac size rather than function in healthy adults
  371. CardioPulse Articles
  372. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation
  373. Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle
  374. Long-term endurance sport is a risk factor for development of lone atrial flutter
  375. Pulmonary Vascular Resistance as Assessed by Bicycle Stress Echocardiography in Patients With Atrial Septal Defect Type Secundum
  376. Strenuous endurance exercise: is more better for everyone? Our genes won't tell us
  377. Clinical Consequences of Intense Endurance Exercise Must Include Assessment of the Right Ventricle
  378. Right ventricular function by strain echocardiography
  379. One- and Two-dimensional Estimation of Right and Left Ventricular Size and Function—Comparison with Cardiac Magnetic Resonance Imaging Volumetric Analysis
  380. Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise
  381. Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin
  382. Continuing Medical Education Program inEchocardiography
  383. Left Ventricular Torsion Parameters are Affected by Acute Changes in Load
  384. The echocardiographic assessment of the right ventricle: what to do in 2010?
  385. Left ventricular strain and strain rate: characterization of the effect of load in human subjects
  386. Three-dimensional cardiac rotational angiography: effective radiation dose and image quality implications
  387. The Fontan circulation: who controls cardiac output?
  388. Left Ventricular Untwisting Is an Important Determinant of Early Diastolic Function
  389. Athlete's Heart: The Potential for Multimodality Imaging to Address the Critical Remaining Questions
  390. Apical ballooning syndrome during treatment with a vascular endothelial growth factor receptor antagonist
  391. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise
  392. Augmentation of Left Ventricular Torsion with Exercise is Attenuated with Age
  393. Reduced and delayed untwisting of the left ventricle in patients with hypertension and left ventricular hypertrophy: a study using two-dimensional speckle tracking imaging
  394. Effect of Heart Rate on Tissue Doppler Measures of Diastolic Function
  395. Exercise—Is it Possible to Have Too Much of a Good Thing?
  396. No Evidence of Sustained Myocardial Injury Following an Ironman Distance Triathlon